Poland· PL-100209270
Rocuronium Kabi
A rocuronium bromide product containing rocuronii bromidum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rocuronium bromide is registered in 13 of 19 countries.
Countries holding a registration under ATC M03AC09 (rocuronium bromide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Rocuronium bromide · ATC M03AC09
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Rocuronii bromidum
- Manufacturer
- Fresenius Kabi Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- M03AC09
- ATC class
- Rocuronium bromide
- Defined daily dose
- 42 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 8
- gtin05909990700288
- gtin05909990700295
- gtin05909990700318
- gtin05909990700325
- gtin05909990700271
- gtin05909990700301
- gtin04052682075704
- gtin04052682075711
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
109 interactions on record for rocuronium bromide.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rocuronium bromide · interactions on record
109 records
- 12 severe
- 59 moderate
- 4 minor
- 34 info
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rocuronium bromide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRocuroniumFresenius Kabi USA, LLC
- CzechiaESMERONMerck Sharp & Dohme B.V., Haarlem
- BelgiumRocuronium B. Braun 10 mg/mlB. Braun Melsungen
- FinlandEsmeronMerck Sharp & Dohme B.V.
- IrelandEsmeron 10 mg/ml solution for injection/infusionMerck Sharp & Dohme Ireland (Human Health) Limited
- SpainESMERON 10 mg/ml SOLUCION INYECTABLE Y PARA PERFUSIONSchering Plough S.A.
- SwedenRocuronium B. Braun 10 mg/ml Injektions-/infusionsvätska, lösningB. Braun Melsungen AG
- NorwayRocuronium bromide KalceksAS Kalceks
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Rocuronium Kalceks, Rocuroniumbromid Accord
- Belgium · Esmeron, Rocuronium B. Braun
- Bulgaria · Рокурониев Ромфарм, Рокурониум Б. Браун
- Cyprus · Esmeron, Rocudem
- Czechia · Esmeron, Rocuronium B. Braun
- Germany · Rocuronium Aguettant, Rocuronium Inresa
- Denmark · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
- Estonia · Rocuronium Bromide Fresenius Kabi, Rocuronium Bromide Kalceks
- Spain · Rocuronio Aguettant, Rocuronio B. Braun
- Finland · Rocuronium B. Braun, Rocuronium Bromide Accord
- France · Rocuronium, Rocuronium Aguettant
- United Kingdom (Northern Ireland) · Esmeron, Rocuronium B. Braun Melsungen
- Greece · Esmeron, Rocudem
- Croatia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Fresenius Kabi
- Hungary · Rocuronium Bromide Hameln, Rocuronium Bromide Noridem
- Ireland · Esmeron, Rocuronium
- Iceland · Rocuronium Aguettant
- Italy · Esmeron, Rocuronio Accord
- Lithuania · Rocuronium Bromide Kalceks, Roqurum
- Luxembourg · Esmeron, Rocuronium Bromide Aguettant
- Latvia · Rocuronium Bromide Kalceks
- Malta · Rocuronium Bromide As Kalceks, Rocuronium Bromide Ibigen
- Netherlands · Esmeron, Rocuroniumbromide Accord
- Norway · Rocuronium Bromide Accord, Rocuronium Bromide Aguettant
- Portugal · Brometo De Rocurónio Accord, Brometo De Rocurónio Aguettant
- Romania · Esmeron, Rocuronium Aguettant
- Sweden · Rocuronium Accord, Rocuronium B. Braun
- Slovenia · Rokuronijev Bromid B. Braun, Rokuronijev Bromid Hameln
- Slovakia · Rocuronium B. Braun, Rocuronium Bromide Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c51ca789-3d95-48ba-8b40-9f6b392457f4 GET /v1/drugs/c51ca789-3d95-48ba-8b40-9f6b392457f4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań lub infuzji",
"source": "urpl",
"strength": "10 mg/ml",
"packaging": "05909990700288 ¦ Rp ¦ 50133\n5 fiol. 5 ml\n05909990700295 ¦ Rp ¦ 50134\n5 fiol. 10 ml\n05909990700318 ¦ Rp ¦ Skasowane ¦ 50136\n10 fiol. 5 ml\n05909990700325 ¦ Rp ¦ Skasowane ¦ 50137\n10 fiol. 10 ml\n05909990700271 ¦ Rp ¦ Skasowane ¦ 151963\n5 fiol. 2,5 ml\n05909990700301 ¦ Rp ¦ Skasowane ¦ 151964\n10 fiol. 2,5 ml\n04052682075704 ¦ Rp ¦ 157819\n10 fiol. 5 ml\n04052682075711 ¦ Rp ¦ 157820\n10 fiol. 10 ml",
"substance": "Rocuronii bromidum 10 mg/ml",
"common_name": "Rocuronii bromidum",
"pl_product_id": "100209270",
"pozwolenie_nr": "15531",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about rocuronium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.